Copaxone and Oral candidiasis - a phase IV clinical study of FDA data
Oral candidiasis is found among people who take Copaxone, especially for people who are female, 60+ old, have been taking the drug for 6 - 12 months.
The phase IV clinical study analyzes which people take Copaxone and have Oral candidiasis. It is created by eHealthMe based on reports of 53,633 people who have side effects when taking Copaxone from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
53,633 people reported to have side effects when taking Copaxone.
Among them, 34 people (0.06%) have Oral candidiasis.
What is Copaxone?
Copaxone has active ingredients of glatiramer acetate. It is often used in multiple sclerosis. eHealthMe is studying from 54,216 Copaxone users for its effectiveness, alternative drugs and more.
What is Oral candidiasis?
Oral candidiasis (fungal infection of mouth) is found to be associated with 1,888 drugs and 1,178 conditions by eHealthMe.
Number of Copaxone and Oral candidiasis reports submitted per year:
Time on Copaxone when people have Oral candidiasis *:
- < 1 month: 0.0 %
- 1 - 6 months: 0.0 %
- 6 - 12 months: 100 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
Gender of people who have Oral candidiasis when taking Copaxone *:
- female: 75.76 %
- male: 24.24 %
Age of people who have Oral candidiasis when taking Copaxone *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 5.56 %
- 30-39: 5.56 %
- 40-49: 22.22 %
- 50-59: 22.22 %
- 60+: 44.44 %
Common drugs people take besides Copaxone *:
- Zofran: 8 people, 23.53%
- Ritalin: 7 people, 20.59%
- Xyrem: 7 people, 20.59%
- Effexor: 7 people, 20.59%
- Albuterol: 6 people, 17.65%
- Gilenya: 6 people, 17.65%
- Methylprednisolone: 6 people, 17.65%
- Baclofen: 6 people, 17.65%
- Abilify: 5 people, 14.71%
- Clonidine: 5 people, 14.71%
Common side effects people have besides Oral candidiasis *:
- High Blood Pressure: 13 people, 38.24%
- Urinary Tract Infection: 11 people, 32.35%
- Weakness: 10 people, 29.41%
- Back Pain: 9 people, 26.47%
- Sepsis (a severe blood infection that can lead to organ failure and death): 8 people, 23.53%
- Dizziness: 8 people, 23.53%
- Confusional State: 8 people, 23.53%
- Nausea And Vomiting: 7 people, 20.59%
- Nausea (feeling of having an urge to vomit): 7 people, 20.59%
- Infection: 7 people, 20.59%
Common conditions people have *:
- Cataplexy (loss of muscle tone accompanied by full conscious awareness): 7 people, 20.59%
- Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 7 people, 20.59%
- Depression: 6 people, 17.65%
- Muscle Spasms (muscle contraction): 5 people, 14.71%
- Bladder Disorder: 5 people, 14.71%
- Stress And Anxiety: 5 people, 14.71%
- Insomnia (sleeplessness): 2 people, 5.88%
- High Blood Pressure: 1 person, 2.94%
- Asthma: 1 person, 2.94%
- Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 1 person, 2.94%
* Approximation only. Some reports may have incomplete information.
Do you take Copaxone and have Oral candidiasis?Check whether Oral candidiasis is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Michaud CJ, Bockheim HM, Nabeel M, Daum TE, "Diagnosis of Exclusion: A Case Report of Probable Glatiramer Acetate-Induced Eosinophilic Myocarditis", Case reports in neurological medicine, 2014 Jul .
How severe was Oral candidiasis and when was it recovered:
Expand to all the drugs that have ingredients of glatiramer acetate:
Alternative drugs to, pros and cons of Copaxone:
- Copaxone (54,216 reports)
Common Copaxone side effects:
- Fatigue (feeling of tiredness): 3,382 reports
- Drug ineffective: 3,348 reports
- Breathing difficulty: 2,754 reports
- Weakness: 2,623 reports
- Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2,596 reports
Browse all side effects of Copaxone:a b c d e f g h i j k l m n o p q r s t u v w x y z
Oral candidiasis treatments and more:
- Oral candidiasis (17,214 reports)
COVID vaccines that are related to Oral candidiasis:
- Oral candidiasis in Moderna COVID Vaccine
- Oral candidiasis in Pfizer BioNTech Covid Vaccine
- Oral candidiasis in Johnson and Johnson Covid Vaccine
Common drugs associated with Oral candidiasis:
- Prednisone: 1,664 reports
- Methotrexate: 955 reports
- Aspirin: 634 reports
- Omeprazole: 626 reports
- Humira: 587 reports
- Nystatin: 563 reports
- Fluconazole: 562 reports
- Prednisolone: 557 reports
- Spiriva: 521 reports
- Enbrel: 520 reports
All the drugs that are associated with Oral candidiasis:
- Oral candidiasis (1,888 drugs)
Common conditions associated with Oral candidiasis:
- Rheumatoid arthritis: 1,070 reports
- Asthma: 881 reports
- High blood pressure: 625 reports
- Chronic obstructive pulmonary disease: 605 reports
- Psoriasis: 512 reports
- Pain: 411 reports
- Multiple myeloma: 409 reports
- Osteoporosis: 407 reports
All the conditions that are associated with Oral candidiasis:
- Oral candidiasis (1,178 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on glatiramer acetate (the active ingredients of Copaxone) and Copaxone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Rocephin and Renal Cyst - 4 seconds ago
- Prempro and Skin Blushing/Flushing - 5 seconds ago
- Melphalan Hydrochloride and Zyloprim drug interaction - 5 seconds ago
- Ginger and Acetaminophen And Hydrocodone Bitartrate drug interaction - 9 seconds ago
- Amoxicillin and Ziextenzo drug interaction - 9 seconds ago
- Dovonex and Gastritis - 20 seconds ago
- Topamax vs. Calan - 23 seconds ago
- Paracetamol vs. Oxaprozin - 24 seconds ago
- Atrovent and Flumazenil drug interaction - 26 seconds ago
- Vesicare and Nasal Discomfort - 33 seconds ago